Most relevant risk stratification schemes derived in different settings than VTE
. | HAS-BLED38 . | mOBRI39 . | ATRIA78 . | HEMORR2HAGES40 . |
---|---|---|---|---|
Risk factors | ||||
Age ≥64 y | 1 point | |||
Age >65 y | 1 point | |||
Age >75 y | 2 points | 1 point | ||
Previous bleeding | 1 point | 1 point | 2 points | |
Previous gastrointestinal bleeding | 1 point | |||
Hepatic or renal disease | 1 point | |||
Renal failure/insufficiency | 1 point | 3 points | ||
Liver failure | 1 point | |||
Previous stroke | 1 point | 1 point | 1 point | |
Anemia | 3 points | 1 point | ||
Antiplatelet therapy | 1 point | |||
Labile international normalized ratio | 1 point | |||
CYP2C9 single-nucleotide polymorphisms | 1 point | |||
Excessive fall risk | 1 point | |||
Reduced platelet count or function | 1 point | |||
History of hypertension | 1 point | 1 point | 1 point | |
Recent myocardial infarction, renal insufficiency, diabetes, or anemia | 1 point | |||
Drugs/alcohol use | 1 point | |||
Risk stratification | ||||
Low risk | 0 points | 0 points | 0 to 3 points | 0 to 1 points |
Intermediate risk | 1 to 2 points | 1 to 2 points | 4 points | 2 to 3 points |
High risk | >2 points | >2 points | >4 points | >3 points |
. | HAS-BLED38 . | mOBRI39 . | ATRIA78 . | HEMORR2HAGES40 . |
---|---|---|---|---|
Risk factors | ||||
Age ≥64 y | 1 point | |||
Age >65 y | 1 point | |||
Age >75 y | 2 points | 1 point | ||
Previous bleeding | 1 point | 1 point | 2 points | |
Previous gastrointestinal bleeding | 1 point | |||
Hepatic or renal disease | 1 point | |||
Renal failure/insufficiency | 1 point | 3 points | ||
Liver failure | 1 point | |||
Previous stroke | 1 point | 1 point | 1 point | |
Anemia | 3 points | 1 point | ||
Antiplatelet therapy | 1 point | |||
Labile international normalized ratio | 1 point | |||
CYP2C9 single-nucleotide polymorphisms | 1 point | |||
Excessive fall risk | 1 point | |||
Reduced platelet count or function | 1 point | |||
History of hypertension | 1 point | 1 point | 1 point | |
Recent myocardial infarction, renal insufficiency, diabetes, or anemia | 1 point | |||
Drugs/alcohol use | 1 point | |||
Risk stratification | ||||
Low risk | 0 points | 0 points | 0 to 3 points | 0 to 1 points |
Intermediate risk | 1 to 2 points | 1 to 2 points | 4 points | 2 to 3 points |
High risk | >2 points | >2 points | >4 points | >3 points |